Biomedical Research Department, ICI Pharmaceuticals Group, Wilmington, Delaware 19897 U.S.A.
Abstract:
The synthesis of a series of tricyclic quinoxalines is described. These compounds exhibit good affinity for both the strychnine-insensitive glycine site of the NMDA receptor and the AMPA receptor.